| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-08 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.26 | 1e-07 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.36 | 2e-07 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-07 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.23 | 1e-06 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.32 | 5e-06 |